Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel candidate drug for heart failure completes phase I trial

Aug. 30, 2012

Candidate analgesic releases pregabalin and nitric oxide

Aug. 30, 2012

Biomarker has prognostic value in patients with diabetes and coronary artery disease

Aug. 29, 2012

Bristol-Myers Squibb presents in vivo results on new Trk inhibitors

Aug. 29, 2012

Theravance product shows strong antinociceptive activity across a range of pain models

Aug. 29, 2012

Preclinical data support clinical testing of new antiarrhythmic drug

Aug. 29, 2012

Tenascin-C evaluated as a marker of isolated noncompaction cardiomyopathy

Aug. 29, 2012

DNA decoy to prevent postsurgical pain shows promising preclinical toxicity profile

Aug. 29, 2012

New alpha2C-adrenoceptor agonists discovered at Merck & Co.

Aug. 28, 2012

PARAMOUNT study reveals beneficial effects of LCZ-696

Aug. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...